Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
Clinical trial NCT04650724 · COMPLETED
Trial details
- NCT number
- NCT04650724
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2018-12-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.